This helps reduce hunger and increase feelings of fullness, making it easier to follow a low-calorie diet
As a significant gut hormone, PYY is receiving attention in the treatment strategies of obesity and other metabolic disorders, particularly in combination therapies with other incretins
Products are evaluated according to established quality-control procedures before release, helping ensure consistency, identity verification, and batch traceability
Key Points Semaglutide (Ozempic, Wegovy) works by targeting one hormone (GLP-1), while tirzepatide (Mounjaro, Zepbound) targets two hormones (GLP-1 and GIP) for a dual-action effect
However, it has shown remarkable efficacy in promoting weight loss
The medication is contraindicated for patients with personal or family history of these problems